收藏切换
The current situation and prospect of clinical trials of boron neutron capture therapy in China
收藏切换
PDF
Jing-long HE1, 2, Xin TONG2, 3, Jun LÜ2, 3, Yan-ru LIU1, Zhi-min YANG2, 3
Chinese Journal of Clinical Pharmacology | 2026, 42(6) : 873 - 878
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(6): 873-878
Review
The current situation and prospect of clinical trials of boron neutron capture therapy in China
Full
Jing-long HE1, 2, Xin TONG2, 3, Jun LÜ2, 3, Yan-ru LIU1, Zhi-min YANG2, 3
Affiliations
  • 1.Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection of NMPA, Shenzhen 518000, Guangdong Province, China
  • 2.State Key Laboratory of Drug Regulatory Science, Beijing 102629, China
  • 3.Center for Drug Evaluation of NMPA, Beijing 100163, China
Published: 2026-03-28 doi: 10.13699/j.cnki.1001-6821.2026.06.019
Outline
收藏切换

Boron neutron capture therapy (BNCT) is an emerging precise tumor therapy, characterized by its ability to kill tumor cells while minimizing damage to normal tissues. In recent years, BNCT has made significant breakthroughs in the research of malignant tumor treatment. This article introduces the basic principles, treatment characteristics, and overseas clinical research status of BNCT, focuses on the current situation of clinical trials of BNCT in China, analyzes the problems existing in the clinical application, and looks forward to the future development prospects of BNCT, with the aim of providing reference for the high-quality development of China’s BNCT industry in the future.

boron neutron capture therapy  /  clinical trials  /  new drug  /  high-end medical equipment
Jing-long HE, Xin TONG, Jun LÜ, Yan-ru LIU, Zhi-min YANG. The current situation and prospect of clinical trials of boron neutron capture therapy in China[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (6) : 873 -878 . DOI: 10.13699/j.cnki.1001-6821.2026.06.019
Year 2026 volume 42 Issue 6
PDF
140
35
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.06.019
  • Receive Date:2026-04-02
  • Online Date:2026-08-06
  • Published:2026-03-28
Article Data
Affiliations
History
  • Received:2026-04-02
Funding
Affiliations
    1.Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection of NMPA, Shenzhen 518000, Guangdong Province, China
    2.State Key Laboratory of Drug Regulatory Science, Beijing 102629, China
    3.Center for Drug Evaluation of NMPA, Beijing 100163, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.06.019
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT